astellas agree that vical stock worth at least 1 dollar. ( that's 16% from yesterday close )
the new drug at least worth 20 million as an assets for vical and should add 20 % above the 16% above.
add on a few percentage as a vote of confidence that reflect vical confidence about there current programs prospects.
not pessimistic but the first 10 baggers is the hard thing. the second ten bagger is only a double from a 900 million market cap to 1.8 billion. not hard to achieve for a 1 billion a year herpes vaccine
my prediction if they demonstrate 50 to 60 present efficacy one big shot like Merck will invest 60 million for a 10 percent of the company ( or a combination of investment and upfront license ) and partner on the program.
that's could happen 2 months max from now. and that's a 10 bagger for a start
or they will watch the OLED get dominated by the Asians. I know that they have a joint venture with Samsung but will that be enough to capitalize on this tremendous opportunity ?
I think its short showing force and giving the impression that shares available in big blocks. we know this kind of block of shares are real without moving the stock at least 1 point in either direction